Parcion Private Wealth’s Gilead Sciences GILD Stock Holding History

Parcion Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$275K	Buy	1,973 +297	+18%	+$41.6K	0.02%	349
2025 Q4	$206K	Sell	1,676 -1,006	-38%	-$122K	0.01%	403
2025 Q3	$298K	Buy	2,682 +308	+13%	+$35K	0.02%	276
2025 Q2	$263K	Buy	2,374 +427	+22%	+$45.4K	0.02%	253
2025 Q1	$218K	Buy	+1,947	New	+$201K	0.02%	261
2024 Q1	–	Sell	-2,701	Closed	-$219K	–	197
2023 Q4	$219K	Hold	2,701	–	–	0.02%	181
2023 Q3	$202K	Buy	+2,701	New	+$208K	0.02%	179

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parcion Private Wealth's GILD Position: Q1 2026 in Review

Parcion Private Wealth increased its Gilead Sciences (GILD) stake by 18% in Q1 2026, buying an estimated $41.6K and bringing the position to 1,973 shares worth $275K. The position accounts for 0.02% of the portfolio, ranked #349.

Parcion Private Wealth first reported a position in GILD in Q3 2023 and has held it in 7 quarters since. The position peaked at $298K in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Parcion Private Wealth held 1,973 shares of Gilead Sciences worth $275K as of Q1 2026.
Parcion Private Wealth bought 297 Gilead Sciences shares in Q1 2026, an estimated $41.6K.
Gilead Sciences made up 0.02% of Parcion Private Wealth's portfolio in Q1 2026, its #349 holding.
Parcion Private Wealth first reported a position in Gilead Sciences in Q3 2023 and has held it in 7 quarters since.
Parcion Private Wealth's Gilead Sciences position peaked at $298K in Q3 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Parcion Private Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.